CD4 and sarcoidosis: To do so, cultured sarcoidosis PBMCs were pre-treated with echinomycin in vitro, then activated with anti-CD3 in the presence of rIL-2, followed by determination of activated CD4+CD25+ T-cells by flow cytometry and measurement of cytokines by ELISA.